Bioqual, Inc. (OTCMKTS:BIOQ – Get Free Report)’s stock price was down 0.7% on Friday . The stock traded as low as $67.00 and last traded at $67.00. Approximately 100 shares traded hands during trading, an increase of 12,400% from the average daily volume of 1 shares. The stock had previously closed at $67.50.
Bioqual Price Performance
The business has a 50-day moving average of $67.47 and a 200-day moving average of $69.95.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported ($0.76) earnings per share for the quarter. The business had revenue of $11.77 million for the quarter. Bioqual had a negative return on equity of 2.87% and a negative net margin of 1.99%.
Bioqual Dividend Announcement
Bioqual Company Profile
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Featured Articles
- Five stocks we like better than Bioqual
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- What is the Dogs of the Dow Strategy? Overview and Examples
- Fast-Growing Companies That Are Still Undervalued
- ETF Screener: Uses and Step-by-Step Guide
- Top Cybersecurity Stock Picks for 2025
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.